Global Point of Care (POC) Analyzers Clinical Pipeline Research Report 2023: Stages of Development, Key Segments, Region and Countries, Regulatory Path and Competitive Landscape

News provided by

Jan 16, 2024, 12:30 ET

DUBLIN, Jan. 16, 2024 /PRNewswire/ -- The "Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Point of Care (POC) Analyzers Pipeline Report provides comprehensive information about the Point of Care (POC) Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

This report provides extensive coverage of Point of Care (POC) Analyzers under development, offering comprehensive insights into pipeline products, major players, developmental activities, clinical trial data, and recent developments in the segment/industry. The report reviews the details of major pipeline products, including product descriptions, licensing and collaboration details, and other developmental activities related to POC Analyzers. It also lists all the pipeline projects involving major players engaged in the development of POC Analyzers.

Coverage of pipeline products is based on various stages of development, ranging from Early Development to Approved/Issued stages, allowing readers to understand the progress of these products in the pipeline. Key clinical trial data related to ongoing trials specific to pipeline products in the POC Analyzers segment is provided, offering valuable insights into the clinical development of these products.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Point of Care (POC) Analyzers under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Point of Care (POC) Analyzers Overview

3 Products under Development
3.1 Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
3.2 Point of Care (POC) Analyzers - Pipeline Products by Segment
3.3 Point of Care (POC) Analyzers - Pipeline Products by Territory
3.4 Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
3.5 Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
3.6 Point of Care (POC) Analyzers - Ongoing Clinical Trials

4 Point of Care (POC) Analyzers - Pipeline Products under Development by Companies
4.1 Point of Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
4.2 Point of Care (POC) Analyzers - Pipeline Products by Stage of Development

5 Point of Care (POC) Analyzers Companies and Product Overview

6 Point of Care (POC) Analyzers- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

Access Bio Inc
Acousort AB
Acrongenomics Inc (Inactive)
AgPlus Diagnostics LTD
Akonni Biosystems Inc
Alere Inc
All Medicus Co Ltd
Analytical Diagnostic Solutions Inc
ApoCell Inc
Aptatek BioSciences Inc
AquaBioChip, LLC
Atonomics A/S (Inactive)
Aviv Biomedical, Inc.
Besst Test
Binghamton University
Bio-AMD Inc
BioMedomics Inc
Biopico Systems Inc
Biosensia Ltd
Boston University
BreviTest Technologies LLC
Brigham and Women's Hospital
Canon USA Inc
Center for Innovation in Point-of-Care Technologies for HIV/AIDS
ChipCare Corp
Chrogene Aarogyam Biotech Pvt Ltd
Chronus Health Inc
City, University of London
Co-Diagnostics Inc
Cornell University
Curetis GmbH
Duke University
Edan Instruments Inc
EKF Diagnostics Holdings Plc
Electrocyt, Inc.
Emergent Detection Inc (Inactive)
Endeavor Sciences Inc
Entegrion Inc
ExcitePCR Corp
Fable Biyoteknoloji San ve Tic AS
Fawkes Biotechnology LLC
First Light Diagnostics Inc
Florida International University
Future Diagnostics Solutions BV
General Fluidics Corp
Giner Inc
GlucoSentient Inc
Glyconics Ltd
Haemokinesis Pty Ltd
HemoPalm Corp
IdbyDNA Inc
Indian Institute of Science
Intelligent Optical Systems, Inc.
Invivomon Inc (Inactive)
I-Sens Inc
LabNow Inc (Inactive)
LightDeck Diagnostics Inc
Louisiana State University
Lucendi Inc
Masaryk University
Maxygen-mobile DNA tests
McKesson Corp
Memorial Sloan Kettering Cancer Center
MobioSense Inc
MyMD Pharmaceuticals Inc
Nalia Systems Ltd
Nanomix Inc
NeuroCatch Inc
Newcastle University
Nikkiso Co Ltd
Nova Biomedical Corp
Novel Microdevices LLC
Ohmx Corp
OncoGenesis
Ontera Inc (Inactive)
Oregon State University
Pacific Nanoscience, Inc.
POC Medical Systems Inc
Prominex Inc
Qvella Corp
Radisens Diagnostics Ltd
Rapid Diagnostic Pvt Ltd
RMIT University
Samvardhana Motherson Health Solution Ltd
Scryb Inc
SeLux Diagnostics Inc
SenGenix Inc
SepTec
Smiths Detection Inc
StemTek Therapeutics SL
Sugentech Inc
Thermal Gradient Inc
ThreeFold Sensors (Inactive)
Trinity Biotech Plc
University of Calgary
University of California Berkeley
University of Glasgow
University of Illinois at Urbana-Champaign
University of Pittsburgh
Ural Federal University
ViroGates AS
Wellstat Diagnostics LLC

For more information about this report visit https://www.researchandmarkets.com/r/hr7u3t

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets